Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. There was just one problem: The technology didn't work.
Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. Carreyrou tells virtually to perfection." - The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. NATIONAL BESTSELLER * The gripping story of Elizabeth Holmes and Theranos-one of the biggest corporate frauds in history-a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist.
0 kommentar(er)
